文献速递真菌感染细菌感染、耐药与抗菌药物医院感染防控

多重耐药念珠菌:流行病学、分子机制与治疗

Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment.
PubMed 文献 · J Infect Dis · 2017-01-01

侵袭性念珠菌感染在住院、免疫抑制或危重患者中仍是重要致病和死亡原因,可用抗真菌药物类别有限。耐药可为固有或获得性,获得性耐药多因个体抗真菌选择压力下出现,少数由耐药株水平传播。多重耐药虽不常见,但光滑念珠菌和耳念珠菌的多重耐药报告增多,驱动因素包括抗真菌药使用、感染部位亚治疗浓度、生物膜基质药物隔离及感染控制欠佳;DNA错配修复基因突变可能促进光滑念珠菌耐药突变获得。

要点

  • 侵袭性念珠菌感染在住院、免疫抑制或危重患者中发病和死亡负担重。
  • 耐药可为固有或获得性,获得性耐药主要因个体抗真菌选择压力或耐药株水平传播。
  • 光滑念珠菌和耳念珠菌多重耐药报告增多,需抗真菌药物管理与感染控制。

核心结论

  • 多重耐药念珠菌虽不常见,但光滑念珠菌和耳念珠菌多重耐药报告增多,抗真菌药物管理对限制多重耐药出现至关重要。

研究设计与样本

  • 本文为综述,围绕侵袭性念珠菌感染的耐药流行病学、分子机制与治疗进行总结。

主要发现

  • 耐药可为固有或获得性,获得性耐药多因个体抗真菌选择压力下出现,少数由耐药株水平传播。
  • 多重耐药报告增多主要见于光滑念珠菌和耳念珠菌。
  • 驱动因素包括整体抗真菌药使用、感染或定植部位亚治疗药物浓度、生物膜基质药物隔离及暴发时感染控制欠佳。
  • 近期研究提示DNA错配修复基因突变可能促进光滑念珠菌耐药突变获得。

临床怎么用

  • 诊断抗真菌耐药念珠菌感染对成功管理患者至关重要。
  • 通过抗真菌药物管理减少不必要抗真菌药使用,以限制多重耐药出现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Invasive Candida infections remain an important cause of morbidity and mortality, especially in hospitalized and immunocompromised or critically ill patients. A limited number of antifungal agents from only a few drug classes are available to treat patients with these serious infections. Resistance can be either intrinsic or acquired. Resistance mechanisms are not exchanged between Candida; thus, acquired resistance either emerges in response to an antifungal selection pressure in the individual patient or, more rarely, occur due to horizontal transmission of resistant strains between patients. Although multidrug resistance is uncommon, increasing reports of multidrug resistance to the azoles, echinocandins, and polyenes have occurred in several Candida species, most notably Candida glabrata and more recently Candida auris. Drivers are overall antifungal use, subtherapeutic drug levels at sites of infection/colonization, drug sequestration in the biofilm matrix, and, in the setting of outbreaks, suboptimal infection control. Moreover, recent research suggests that DNA mismatch repair gene mutations may facilitate acquisition of resistance mutations in C. glabrata specifically. Diagnosis of antifungal-resistant Candida infections is critical to the successful management of patients with these infections. Reduction of unnecessary use of antifungals via antifungal stewardship is critical to limit multidrug resistance emergence.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Arendrup MC, Patterson TF. Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment. J Infect Dis. 2017. PMID: 28911043. doi:10.1093/infdis/jix131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。